Safety and Efficacy of Avonex in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2004
The purpose of this study is to determine whether AVONEX (Interferon Beta-1a), when compared to placebo, reduces the total dose of IVIg that is administered after Visit 5 and through Visit 9 (Week 32, End of Study).
Epistemonikos ID: ded4043429df78ada50da4dc6f7989d612673d72
First added on: Mar 31, 2022